Cargando…
Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside
Autores principales: | Radovanovic, Dejan, Santus, Pierachille, Blasi, Francesco, Mantero, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461730/ https://www.ncbi.nlm.nih.gov/pubmed/28593046 http://dx.doi.org/10.1186/s40248-017-0099-y |
Ejemplares similares
-
The evidence on tiotropium bromide in asthma: from the rationale to the bedside
por: Radovanovic, Dejan, et al.
Publicado: (2017) -
Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
por: Mantero, Marco, et al.
Publicado: (2018) -
Mucins and Asthma: Are We Headed to the Revolutionary Road?
por: Santus, Pierachille, et al.
Publicado: (2019) -
Tiotropium bromide
por: Lipson, David A
Publicado: (2006) -
Erratum to: A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids
por: Vogelberg, Christian, et al.
Publicado: (2015)